| Identification | Back Directory | [Name]
2-Amino-9-[(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)]-9H-purine | [CAS]
1260177-41-0 | [Synonyms]
9-(2',3',5'-Tri-O-benzoyl-b-D-ribofuranosyl)-2-chloropurine
2-Chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine
9H-Purine, 2-chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-
2-Amino-9-[(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)]-9H-purine
2-chloro-9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-9H-purine
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(2-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate | [Molecular Formula]
C16H17ClN4O7 | [MDL Number]
MFCD31707471 | [MOL File]
1260177-41-0.mol | [Molecular Weight]
412.78 |
| Hazard Information | Back Directory | [Uses]
2-Chloro-9-[(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)]-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList1701258/0_EN.htm |
|